Literature DB >> 28062398

Perineural Invasion and Risk of Lethal Prostate Cancer.

Piotr Zareba1, Richard Flavin2,3, Masis Isikbay4, Jennifer R Rider5,6, Travis A Gerke6,7, Stephen Finn2,3, Andreas Pettersson6,8, Francesca Giunchi9, Robert H Unger6, Alex M Tinianow6, Swen-Olof Andersson10,11, Ove Andrén10,11, Katja Fall6,11, Michelangelo Fiorentino2,9, Lorelei A Mucci12,13,14.   

Abstract

Background: Prostate cancer has a propensity to invade and grow along nerves, a phenomenon called perineural invasion (PNI). Recent studies suggest that the presence of PNI in prostate cancer has been associated with cancer aggressiveness.
Methods: We investigated the association between PNI and lethal prostate cancer in untreated and treated prostate cancer cohorts: the Swedish Watchful Waiting Cohort of 615 men who underwent watchful waiting, and the U.S. Health Professionals Follow-Up Study of 849 men treated with radical prostatectomy. One pathologist performed a standardized histopathologic review assessing PNI and Gleason grade. Patients were followed from diagnosis until metastasis or death.
Results: The prevalence of PNI was 7% and 44% in the untreated and treated cohorts, respectively. PNI was more common in high Gleason grade tumors in both cohorts. PNI was associated with enhanced tumor angiogenesis, but not tumor proliferation or apoptosis. In the Swedish study, PNI was associated with lethal prostate cancer [OR 7.4; 95% confidence interval (CI), 3.6-16.6; P < 0.001]. A positive, although not statistically significant, association persisted after adjustment for age, Gleason grade, and tumor volume (OR 1.9; 95% CI, 0.8-5.1; P = 0.17). In the U.S. study, PNI predicted lethal prostate cancer independent of clinical factors (HR 1.8; 95% CI, 1.0, 3.3; P =0.04).Conclusions: These data support the hypothesis that perineural invasion creates a microenvironment that promotes cancer aggressiveness.Impact: Our findings suggest that PNI should be a standardized component of histopathologic review, and highlights a mechanism underlying prostate cancer metastasis. Cancer Epidemiol Biomarkers Prev; 26(5); 719-26. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2017        PMID: 28062398      PMCID: PMC5413395          DOI: 10.1158/1055-9965.EPI-16-0237

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  62 in total

1.  Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.

Authors:  Stephen J Freedland; Elizabeth B Humphreys; Leslie A Mangold; Mario Eisenberger; Frederick J Dorey; Patrick C Walsh; Alan W Partin
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

2.  Biological significance of perineural invasion (PNI) in prostate cancer.

Authors:  Gaëlle Fromont; Julie Godet; Christophe Pires; Mokrane Yacoub; Bertrand Dore; Jacques Irani
Journal:  Prostate       Date:  2011-07-11       Impact factor: 4.104

3.  Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens.

Authors:  N Maru; M Ohori; M W Kattan; P T Scardino; T M Wheeler
Journal:  Hum Pathol       Date:  2001-08       Impact factor: 3.466

4.  Perineural invasion detection in prostate biopsy is related to recurrence-free survival in patients submitted to radical prostatectomy.

Authors:  Betina Katz; Miguel Srougi; Marcos Dall'Oglio; Adriano J Nesrallah; Alexandre C Sant'anna; José Pontes; Alberto A Antunes; Sabrina T Reis; Nayara Viana; Adriana Sañudo; Luiz H Camara-Lopes; Katia R M Leite
Journal:  Urol Oncol       Date:  2011-07-27       Impact factor: 3.498

5.  Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden.

Authors:  J E Johansson; L Holmberg; S Johansson; R Bergström; H O Adami
Journal:  JAMA       Date:  1997-02-12       Impact factor: 56.272

6.  Prediction of perineural invasion and its prognostic value in patients with prostate cancer.

Authors:  Jun Taik Lee; Seungsoo Lee; Chang Jin Yun; Byung Joo Jeon; Jung Man Kim; Hong Koo Ha; Wan Lee; Moon Kee Chung
Journal:  Korean J Urol       Date:  2010-11-17

7.  Cancer-related axonogenesis and neurogenesis in prostate cancer.

Authors:  Gustavo E Ayala; Hong Dai; Michael Powell; Rile Li; Yi Ding; Thomas M Wheeler; David Shine; Dov Kadmon; Timothy Thompson; Brian J Miles; Michael M Ittmann; David Rowley
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

8.  Growth and survival mechanisms associated with perineural invasion in prostate cancer.

Authors:  Gustavo E Ayala; Hong Dai; Michael Ittmann; Rile Li; Michael Powell; Anna Frolov; Thomas M Wheeler; Timothy C Thompson; David Rowley
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

9.  Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy.

Authors:  Hsiang-Hsuan M Yu; Danny Y Song; Ya-Yu Tsai; Travis Thompson; Deborah A Frassica; Theodore L DeWeese
Journal:  Urology       Date:  2007-07       Impact factor: 2.649

10.  Natural history of early, localized prostate cancer.

Authors:  Jan-Erik Johansson; Ove Andrén; Swen-Olof Andersson; Paul W Dickman; Lars Holmberg; Anders Magnuson; Hans-Olov Adami
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

View more
  17 in total

1.  GDNF secreted by nerves enhances PD-L1 expression via JAK2-STAT1 signaling activation in HNSCC.

Authors:  Chengzhong Lin; Wei Cao; Zhenhu Ren; Yu Tang; Chunye Zhang; Rong Yang; Yiming Chen; Zheqi Liu; Canbang Peng; Lizhen Wang; Xu Wang; Tong Ji
Journal:  Oncoimmunology       Date:  2017-07-20       Impact factor: 8.110

2.  A Prospective Study of Intraprostatic Inflammation, Focal Atrophy, and Progression to Lethal Prostate Cancer.

Authors:  Yiwen Zhang; Cindy Ke Zhou; Michelangelo Fiorentino; Ericka M Ebot; Emily M Rencsok; Katja Fall; Tamara L Lotan; Massimo Loda; Francesca Giunchi; Elizabeth A Platz; Angelo M De Marzo; Lorelei A Mucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-09-18       Impact factor: 4.254

Review 3.  Tumour innervation and neurosignalling in prostate cancer.

Authors:  Brayden March; Sam Faulkner; Phillip Jobling; Allison Steigler; Alison Blatt; Jim Denham; Hubert Hondermarck
Journal:  Nat Rev Urol       Date:  2020-01-14       Impact factor: 14.432

4.  Regular aspirin use and gene expression profiles in prostate cancer patients.

Authors:  Konrad H Stopsack; Ericka M Ebot; Mary K Downer; Travis A Gerke; Jennifer R Rider; Philip W Kantoff; Lorelei A Mucci
Journal:  Cancer Causes Control       Date:  2018-06-18       Impact factor: 2.506

5.  Spatial and Transcriptomic Analysis of Perineural Invasion in Oral Cancer.

Authors:  Ligia B Schmitd; Cindy Perez-Pacheco; Emily L Bellile; Weisheng Wu; Keith Casper; Michelle Mierzwa; Laura S Rozek; Gregory T Wolf; Jeremy M G Taylor; Nisha J D'Silva
Journal:  Clin Cancer Res       Date:  2022-08-15       Impact factor: 13.801

6.  Single-nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4.

Authors:  Fankai Xiao; Peng Zhang; Yuan Wang; Yijun Tian; Michael James; Chiang-Ching Huang; Lidong Wang; Liang Wang
Journal:  Mol Carcinog       Date:  2019-10-29       Impact factor: 4.784

7.  SNAIL Transctiption factor in prostate cancer cells promotes neurite outgrowth.

Authors:  Gabrielle Edwards; Taaliah Campbell; Veronica Henderson; Alira Danaher; Daqing Wu; Rekha Srinivasan; Khosrow Rezvani; Valerie A Odero-Marah
Journal:  Biochimie       Date:  2020-10-24       Impact factor: 4.079

8.  Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance.

Authors:  Mannan Nouri; Josselin Caradec; Amy Anne Lubik; Na Li; Brett G Hollier; Mandeep Takhar; Manuel Altimirano-Dimas; Mengqian Chen; Mani Roshan-Moniri; Miriam Butler; Melanie Lehman; Jennifer Bishop; Sarah Truong; Shih-Chieh Huang; Dawn Cochrane; Michael Cox; Colin Collins; Martin Gleave; Nicholas Erho; Mohamed Alshalafa; Elai Davicioni; Colleen Nelson; Sheryl Gregory-Evans; R Jeffrey Karnes; Robert B Jenkins; Eric A Klein; Ralph Buttyan
Journal:  Oncotarget       Date:  2017-03-21

9.  Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively.

Authors:  Amar S Ahmad; Vishnu Parameshwaran; Luis Beltran; Gabrielle Fisher; Bernard V North; David Greenberg; Geraldine Soosay; Henrik Møller; Peter Scardino; Jack Cuzick; Daniel M Berney
Journal:  Oncotarget       Date:  2018-04-17

10.  Investigation of Neural Microenvironment in Prostate Cancer in Context of Neural Density, Perineural Invasion, and Neuroendocrine Profile of Tumors.

Authors:  Dawid Sigorski; Jacek Gulczyński; Aleksandra Sejda; Wojciech Rogowski; Ewa Iżycka-Świeszewska
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.